AN ACT Relating to modernizing the all payers claims database by updating reporting requirements, data disclosure standards, and lead organization requirements;
HB 1382 modernizes Washington’s all-payer health care claims database. The bill updates reporting requirements, data disclosure standards, and governance rules for the statewide database, and it transfers oversight from the Office of Financial Management to the Health Care Authority on January 1, 2026. It also requires a transition plan to keep the database operating during the transfer and adds a new expiration date for one of the bill’s sections.
The bill expands and clarifies the types of data the database must collect, including medical, pharmacy, and other claims data from public and private payers, while defining key terms such as direct and indirect patient identifiers, proprietary financial information, unique identifiers, data suppliers, and data vendors. It strengthens privacy and security requirements by limiting access to identifiable or proprietary data, requiring de-identification and encryption, and setting conditions for data use agreements, data destruction, and penalties for misuse. It also directs the lead organization to use a competitive procurement process, establish advisory committees, and meet detailed standards for data quality, security, and reporting.
HB 1382 changes state law governing the all-payer claims database by revising multiple RCW provisions and adding new duties for the Health Care Authority, the lead organization, and the Office of Financial Management. It authorizes broader public reporting on health care cost and quality while restricting publication of information that could identify patients or reveal proprietary payer information. It also requires rules on submission deadlines, fees, release procedures, minimum reporting thresholds, and agency coordination, and it adds a legislative review of state and federal transparency tools related to health care pricing.
The overall sentiment appears generally supportive, as the bill passed both chambers, including committee and floor votes, though not unanimously. The vote margins suggest meaningful but not overwhelming bipartisan support, with some opposition at each stage. That pattern is consistent with a bill that is broadly aimed at improving transparency and data utility, while also imposing significant privacy, governance, and operational requirements.
The main points of contention likely center on privacy, proprietary financial information, and who controls access to the database. The bill places strict limits on identifiable data and on reports that could expose carrier pricing or individual patients, which may have been important to providers, carriers, and self-insured purchasers. Other likely concerns include the transfer of authority to the Health Care Authority, the competitive procurement process for the lead organization, and whether the expanded reporting and advisory structure could increase administrative burden or affect how health care pricing data are used.
The bill amends Washington statutes governing the statewide all-payer claims database, shifting oversight and operational authority from the Office of Financial Management to the Health Care Authority and revising the roles of the lead organization, data vendors, and data suppliers. It also adds new statutory requirements for data collection, privacy protections, public reporting, procurement, advisory committees, fee-setting, and interagency coordination, while creating a new section with an effective date and expiration date for part of the act. These changes affect carriers, hospitals, providers, employers, researchers, public agencies, and other entities that submit, receive, or use claims data.
The bill’s vote history indicates generally favorable sentiment in both the House and Senate, with passage at the committee and floor levels. However, the recorded no votes show that the measure was not universally supported, suggesting some legislators had reservations even while the bill advanced. The lack of committee transcript material limits more detailed insight into debate, but the final outcome indicates the bill was viewed as a workable modernization of the claims database rather than a controversial overhaul.
Likely areas of contention include patient privacy, the handling of proprietary financial information, and the extent to which claims data can be released for public reporting or research. The bill’s detailed restrictions on direct and indirect identifiers, its limits on reports that could identify small provider groups or reveal carrier pricing, and its rules for data-use agreements suggest concerns about misuse or re-identification. There may also have been disagreement over governance changes, especially the transfer of authority to the Health Care Authority, the use of competitive procurement to select the lead organization, and the balance between transparency goals and administrative or compliance burdens on data suppliers and users.